Pemphigus: New approaches to diagnosis and disease severity assessment

Abstract

Pemphigus represents a group of severe and potentially fatal autoimmune bullous diseases. Pemphigus clinical findings represents skin and/or mucous membranes keratinocytes acantholysis with intraepithelial blisters and erosions formation which is life-threatening and, if relapsed, significantly reduce the patients’ quality of life. The on-time disease diagnosis is a key to successful pemphigus management and timely treatment onset allowing intensive disease progression avoidance.

The article reviews up-to-date diagnosing methods and assessment measure for monitoring pemphigus severity. In addition to standard diagnosis methods, such as clinical findings, histological examination, direct and indirect immunofluorescence, and enzyme immunoassay (ELISA), the article focuses on revieing new diagnostic and disease severity prediction approaches, such as microRNAs expression and skin and mucous membranes microbiome analysis since false positive and false negative results in histological and immunohistochemical analysis as well as the laboratories insufficient equipment makes finding pemphigus new diagnostic and prognostic methods a relevant challenge.

Keywords

bullous dermatoses / pemphigus vulgaris / pemphigus foliaceus / micobiome / microRNAs

References

[1] Egu DT, Schmitt T, Waschke J. Mechanisms causing acantholysis in pemphigus-lessons from human skin. Front Immunol. 2022;(13):884067. doi: 10.3389/fimmu.2022.884067

[2] Egu D.T., Schmitt T., Waschke J. Mechanisms causing acantholysis in pemphigus-lessons from human skin // Front Immunol. 2022. N 13. Р. 884067. doi: 10.3389/fimmu.2022.884067

[3] Schmitt T, Pircher J, Steinert L, et al. Dsg1 and Dsg3 composition of desmosomes across human epidermis and alterations in pemphigus vulgaris patient skin. Front Immunol. 2022;(13):884241. doi: 10.3389/fimmu.2022.884241

[4] Schmitt T., Pircher J., Steinert L., et al. Dsg1 and Dsg3 composition of desmosomes across human epidermis and alterations in pemphigus vulgaris patient skin // Front Immunol. 2022. Vol. 13. Р. 884241. doi: 10.3389/fimmu.2022.884241

[5] Tkachenko SB, Teplyuk NP, Allenova AS, Lepekhova AA. On the classification of bullous dermatoses. Russ J Skin Venereal Dis. 2015;18(2):11–14. (In Russ).

[6] Ткаченко С.Б., Теплюк Н.П., Алленова А.С., Лепехова А.А. К вопросу о классификации буллезных дерматозов // Российский журнал кожных и венерических болезней. 2015. Т. 18, № 2. С. 11–14.

[7] Satyam A, Khandpur S, Sharma VK, Sharma A. Involvement of T(H)1/T(H)2 cytokines in the pathogenesis of autoimmune skin disease-Pemphigus vulgaris. Immunol Invest. 2009;38(6):498–509. doi: 10.1080/08820130902943097

[8] Satyam A., Khandpur S., Sharma V.K., Sharma A. Involvement of T(H)1/T(H)2 cytokines in the pathogenesis of autoimmune skin disease-Pemphigus vulgaris // Immunol Invest. 2009. Vol. 38, N 6. Р. 498–509. doi: 10.1080/08820130902943097

[9] Lee SH, Hong WJ, Kim SC. Analysis of serum cytokine profile in pemphigus. Ann Dermatol. 2017;29(4):438–445. doi: 10.5021/ad.2017.29.4.438

[10] Lee S.H., Hong W.J., Kim S.C. Analysis of serum cytokine profile in pemphigus // Ann Dermatol. 2017. Vol. 29, N 4. Р. 438–445. doi: 10.5021/ad.2017.29.4.438

[11] Rizzo C, Fotino M, Zhang Y, et al. Direct characterization of human T cells in pemphigus vulgaris reveals elevated autoantigen-specific Th2 activity in association with active disease. Clin Exp Dermatol. 2005;30(5):535–540. doi: 10.1111/j.1365-2230.2005.01836.x

[12] Rizzo, C., Fotino, M., Zhang, Y., et al. Direct characterization of human T cells in pemphigus vulgaris reveals elevated autoantigen-specific Th2 activity in association with active disease // Clin Experimental Dermatol. 2005. Vol. 30, N 5. Р. 535–540. doi: 10.1111/j.1365-2230.2005.01836.x

[13] Grando SA. Pemphigus autoimmunity: hypotheses and realities. Autoimmunity. 2012;45(1):7–35. doi: 10.3109/08916934.2011.606444

[14] Grando S.A. Pemphigus autoimmunity: Hypotheses and realities // Autoimmunity. 2012. Vol. 45, N 1. Р. 7–35. doi: 10.3109/08916934.2011.606444

[15] Didona D, Maglie R, Eming R, Hertl M. Pemphigus: Current and future therapeutic strategies. Front Immunol. 2019;(10):1418. doi: 10.3389/fimmu.2019.01418

[16] Didona D., Maglie R., Eming R., Hertl M. Pemphigus: Current and future therapeutic strategies // Front Immunol. 2019. N 10. Р. 1418. doi: 10.3389/fimmu.2019.01418

[17] Leshem YA, Gdalevich M, Ziv M, et al. Opportunistic infections in patients with pemphigus. J Am Academy Dermatol. 2014;71(2):284–292. doi: 10.1016/j.jaad.2014.03.020

[18] Leshem Y.A., Gdalevich M., Ziv M., et al. Opportunistic infections in patients with pemphigus // J Am Academy Dermatol. 2014. Vol. 71, N 2. Р. 284–292. doi: 10.1016/j.jaad.2014.03.020

[19] Teplyuk NP, Lepekhova AA. Clinical aspects of steroid resistance in autoimmune pemphigus. Russ J Skin Venereal Dis. 2014;17(2):13–16. (In Russ).

[20] Теплюк Н.П., Лепехова А.А. Клинические аспекты стероидной резистентности при аутоиммунной пузырчатке // Российский журнал кожных и венерических болезней. 2014. Т. 17, № 2. С. 13–16.

[21] Xuan RR, Yang A, Murrell DF. New biochip immunofluorescence test for the serological diagnosis of pemphigus vulgaris and foliaceus: A review of the literature. Int J Women’s Dermatol. 2018;4(2):102–108. doi: 10.1016/j.ijwd.2017.10.001

[22] Xuan R.R., Yang A., Murrell D.F. New biochip immunofluorescence test for the serological diagnosis of pemphigus vulgaris and foliaceus: A review of the literature // Int J Women’s Dermatol. 2018. Vol. 4, N 2. Р. 102–108. doi: 10.1016/j.ijwd.2017.10.001

[23] Joly P, Litrowski N. Pemphigus group (vulgaris, vegetans, foliaceus, herpetiformis, brasiliensis). Clin Dermatol. 2011;29(4):432–436. 10.1016/j.clindermatol.2011.01.013

[24] Joly P., Litrowski N. Pemphigus group (vulgaris, vegetans, foliaceus, herpetiformis, brasiliensis) // Clin Dermatol. 2011. Vol. 29, N 4. Р. 432–436. doi: 10.1016/j.clindermatol.2011.01.013

[25] Lim YL, Bohelay G, Hanakawa S, et al. Autoimmune pemphigus: Latest advances and emerging therapies. Front Molecular Biosci. 2022;(8):808536. doi: 10.3389/fmolb.2021.808536

[26] Lim Y.L., Bohelay G., Hanakawa S., et al. Autoimmune pemphigus: Latest advances and emerging therapies // Front Molecular Biosci. 2022. N 8. Р. 808536. doi: 10.3389/fmolb.2021.808536

[27] Bystryn JC, Rudolph JL. Pemphigus. Lancet (London, England). 2005;366(9479):61–73. doi: 10.1016/S0140-6736(05)66829-8

[28] Bystryn J.C., Rudolph J.L. Pemphigus // Lancet (London, England). 2005. Vol. 366, N 9479. Р. 61–73. doi: 10.1016/S0140-6736(05)66829-8

[29] Kneisel A, Hertl M. Autoimmune bullous skin diseases. Part 1: Clinical manifestations. J Dtsch Dermatol Ges. 2011;9(10):844–857. doi: 10.1111/j.1610-0387.2011.07793.x

[30] Kneisel A., Hertl M. Autoimmune bullous skin diseases. Part 1: Clinical manifestations // J Dtsch Dermatol Ges. 2011. Vol. 9, N 10. Р. 844–857. doi: 10.1111/j.1610-0387.2011.07793.x

[31] Schmidt E, Goebeler M, Hertl M, et al. S2k guideline for the diagnosis of pemphigus vulgaris/foliaceus and bullous pemphigoid. J Dtsch Dermatol Ges. 2015;13(7):713–727. doi: 10.1111/ddg.12612

[32] Schmidt E., Goebeler M., Hertl M., et al. S2k guideline for the diagnosis of pemphigus vulgaris/foliaceus and bullous pemphigoid // J Dtsch Dermatol Ges. 2015. Vol. 13, N 7. Р. 713–727. doi: 10.1111/ddg.12612

[33] Tan JC, Tat LT, Francis KB, et al. Prospective study of ocular manifestations of pemphigus and bullous pemphigoid identifies a high prevalence of dry eye syndrome. Cornea. 2015;34(4):443–448. doi: 10.1097/ICO.0000000000000335

[34] Tan J.C., Tat L.T., Francis K.B., et al. Prospective study of ocular manifestations of pemphigus and bullous pemphigoid identifies a high prevalence of dry eye syndrome // Cornea. 2015. Vol. 34, N 4. Р. 443–448. doi: 10.1097/ICO.0000000000000335

[35] James KA, Culton DA, Diaz LA. Diagnosis and clinical features of pemphigus foliaceus. Dermatol Clin. 2011;29(3):405-viii. doi: 10.1016/j.det.2011.03.012

[36] James K.A., Culton D.A., Diaz L.A. Diagnosis and clinical features of pemphigus foliaceus // Dermatol Clin. 2011. Vol. 29, N 3. Р. 405-viii. doi: 10.1016/j.det.2011.03.012

[37] Harel-Raviv M, Srolovitz H, Gornitsky M. Pemphigus vulgaris: The potential for error. A case report. Spec Care Dentist. 1995;15(2):61–64. doi: 10.1111/j.1754-4505.1995.tb00478.x

[38] Harel-Raviv M., Srolovitz H., Gornitsky M. Pemphigus vulgaris: The potential for error. A case report // Spec Care Dentist. 1995. Vol. 15, N 2. Р. 61–64. doi: 10.1111/j.1754-4505.1995.tb00478.x

[39] Khamaganova IV, Malyarenko EN, Denisova EV, et al. Error in the diagnosis of vulgar pemphigus: A clinical case. Russ J Skin Venereal Dis. 2017;20(1):30–33. (In Russ). doi: 10.18821/1560-9588-2017-20-1-30-33

[40] Хамаганова И.В., Маляренко Е.Н., Денисова Е.В., и др. Ошибка в диагностике вульгарной пузырчатки: клинический случай // Российский журнал кожных и венерических болезней. 2017. Т. 20, № 1. С. 30–33. doi: 10.18821/1560-9588-2017-20-1-30-33

[41] Petrovа SY, Berzhets VM, Radiсova OV. Difficulties of differential diagnosis of blistering dermatoses. Pemphigus erythematosus is a case from clinical practice. Immunopathol Allergol Infectol. 2017;(4):31–36. (In Russ). doi: 10.14427/jipai.2017.4.31

[42] Петрова С.Ю., Бержец В.М., Радикова О.В. Трудности дифференциальной диагностики пузырных дерматозов. Эритематозная пузырчатка: случай из клинической практики // Иммунопатология, аллергология, инфектология. 2017. № 4. С. 31–36. doi: 10.14427/jipai.2017.4.31

[43] Daltaban Ö, Özçentik A, Karakaş A, et al. Clinical presentation and diagnostic delay in pemphigus vulgaris: A prospective study from Turkey. J Oral Pathol Med. 2020;49(7):681–686. doi: 10.1111/jop.13052

[44] Daltaban Ö., Özçentik A., Karakaş A., et al. Clinical presentation and diagnostic delay in pemphigus vulgaris: A prospective study from Turkey // J Oral Pathol Med. 2020. Vol. 49, N 7. Р. 681–686. doi: 10.1111/jop.13052

[45] Morishima-Koyano M, Nobeyama Y, Fukasawa-Momose M, et al. Case of pemphigus foliaceus misdiagnosed as a single condition of erythrodermic psoriasis and modified by brodalumab. J Dermatol. 2020;47(5):e201–e202. doi: 10.1111/1346-8138.15295

[46] Morishima-Koyano M., Nobeyama Y., Fukasawa-Momose M., et al. Case of pemphigus foliaceus misdiagnosed as a single condition of erythrodermic psoriasis and modified by brodalumab // J Dermatol. 2020. Vol. 47, N 5. Р. e201–e202. doi: 10.1111/1346-8138.15295

[47] Siadat AH, Moeine R, Iraji F, et al. Pemphigus vegetans misdiagnosed as condylomata acuminata: A case report. Clin Case Rep. 2022;10(10):e6393. doi: 10.1002/ccr3.6393

[48] Siadat A.H., Moeine R., Iraji F., et al. Pemphigus vegetans misdiagnosed as condylomata acuminata: A case report // Clin Case Rep. 2022. Vol. 10, N 10. Р. e6393. doi: 10.1002/ccr3.6393

[49] Petruzzi M, Vella F, Squicciarini N, et al. Diagnostic delay in autoimmune oral diseases. Oral Dis. 2022. doi: 10.1111/odi.14480

[50] Petruzzi M., Vella F., Squicciarini N., et al. Diagnostic delay in autoimmune oral diseases // Oral Diseases. 2022. doi: 10.1111/odi.14480

[51] Murrell DF, Peña S, Joly P, et al. Diagnosis and management of pemphigus: Recommendations of an international panel of experts. J Am Academy Dermatol. 2020;82(3):575–585.e1. doi: 10.1016/j.jaad.2018.02.021

[52] Murrell D.F., Peñ S., Joly P., et al. Diagnosis and management of pemphigus: Recommendations of an international panel of experts // J Am Academy Dermatol. 2020. Vol. 82, N 3. Р. 575–585.e1. doi: 10.1016/j.jaad.2018.02.021

[53] Xuan RR, Yang A, Murrell DF. New biochip immunofluorescence test for the serological diagnosis of pemphigus vulgaris and foliaceus: A review of the literature. Int J Women’s Dermatol. 2018;4(2):102–108. doi: 10.1016/j.ijwd.2017.10.001

[54] Xuan R.R., Yang A., Murrell D.F. New biochip immunofluorescence test for the serological diagnosis of pemphigus vulgaris and foliaceus: A review of the literature // Int J Women’s Dermatol. 2018. Vol. 4, N 2. Р. 102–108. doi: 10.1016/j.ijwd.2017.10.001

[55] Tkachenko SB, Teplyuk NP, Minnibayev MT, et al. Modern methods of differential diagnosis of true (autoimmune) pemphigus and bullous pemphigoid. Russ J Skin Venereal Dis. 2015;18(3):17–22. (In Russ).

[56] Ткаченко С.Б., Теплюк Н.П., Миннибаев М.Т., и др. Современные методы дифференциальной диагностики истинной (аутоиммунной) пузырчатки и буллезного пемфигоида // Российский журнал кожных и венерических болезней. 2015. Т. 18, № 3. С. 17–22.

[57] Buch AC, Kumar H, Panicker N, et al. A cross-sectional study of direct immunofluorescence in the diagnosis of immunobullous dermatoses. Indian J Dermatol. 2014;59(4):364–368. doi: 10.4103/0019-5154.135488

[58] Buch A.C., Kuma H., Panicker N., et al. A cross-sectional study of direct immunofluorescence in the diagnosis of immunobullous dermatoses // Indian J Dermatol. 2014. Vol. 59, N 4. Р. 364–368. doi: 10.4103/0019-5154.135488

[59] Kridin K, Bergman R. The usefulness of indirect immunofluorescence in pemphigus and the natural history of patients with initial false-positive results: A retrospective cohort study. Front Med. 2018;(5):266. doi: 10.3389/fmed.2018.00266

[60] Kridin K., Bergman R. The usefulness of indirect immunofluorescence in pemphigus and the natural history of patients with initial false-positive results: A retrospective cohort study // Front Med. 2018. N 5. Р. 266. doi: 10.3389/fmed.2018.00266

[61] Makhneva NV, Davidenko EB, Beletskaya LV. Diagnosis and differential diagnosis of autoimmune pemphigus. Almanac Clin Med. 2014;(34):9–14. (In Russ). doi: 10.18786/2072-0505-2014-34-9-14

[62] Махнева Н.В., Давиденко Е.Б., Белецкая Л.В. О проблеме диагностики и дифференциальной диагностики аутоиммунной пузырчатки // Альманах клинической медицины. 2014. № 34. С. 9–14. doi: 10.18786/2072-0505-2014-34-9-14

[63] Malik AM, Tupchong S, Huang S, et al. An updated review of pemphigus diseases. Medicina (Kaunas). 2021;57(10):1080. doi: 10.3390/medicina57101080

[64] Malik A.M., Tupchong S., Huang S., et al. An updated review of pemphigus diseases // Medicina (Kaunas). 2021. Vol. 57, N 10. Р. 1080. doi: 10.3390/medicina57101080

[65] Preclaro IA, Wu YH. Spongiotic pattern in pemphigus: A retrospective observational single-center study. Dermatopathol (Basel). 2022;9(2):172–182. doi: 10.3390/dermatopathology9020022

[66] Preclaro I.A., Wu Y.H. Spongiotic pattern in pemphigus: A retrospective observational single-center study // Dermatopathol (Basel). 2022. Vol. 9, N 2. Р. 172–182. doi: 10.3390/dermatopathology9020022

[67] Manocha A, Tirumalae R. Histopathology of pemphigus vulgaris revisited. Am J Dermatopathol. 2021;43(6):429–437. doi: 10.1097/DAD.0000000000001838

[68] Manocha A., Tirumalae R. Histopathology of pemphigus vulgaris revisited // Am J Dermatopathol. 2021. Vol. 43, N 6. Р. 429–437. doi: 10.1097/DAD.0000000000001838

[69] Schmidt E, Kasperkiewicz M, Joly P. Pemphigus. Lancet. 2019;394(10201):882–894. doi: 10.1016/S0140-6736(19)31778-7

[70] Schmidt E., Kasperkiewicz M., Joly P. Pemphigus // Lancet. 2019. Vol. 394, N 10201. Р. 882–894. doi: 10.1016/S0140-6736(19)31778-7

[71] Saschenbrecker S, Kar I, Komorowski L, et al. Serological diagnosis of autoimmune bullous skin diseases. Front Immunol. 2019;(10):1974. doi: 10.3389/fimmu.2019.01974

[72] Saschenbrecker S., Karl I., Komorowski L., et al. Serological diagnosis of autoimmune bullous skin diseases // Front Immunol. 2019. N 10. Р. 1974. doi: 10.3389/fimmu.2019.01974

[73] Giurdanella F, Nijenhuis AM, Diercks GF, et al. Keratinocyte binding assay identifies anti-desmosomal pemphigus antibodies where other tests are negative. Front Immunol. 2018;(9):839. doi: 10.3389/fimmu.2018.00839

[74] Giurdanella F., Nijenhuis A.M., Diercks G.F., et al. Keratinocyte binding assay identifies anti-desmosomal pemphigus antibodies where other tests are negative // Front Immunol. 2018. N 9. Р. 839. doi: 10.3389/fimmu.2018.00839

[75] Kurbanov AA, Abramova TV. The use of clinical and diagnostic indices in assessing the severity of pemphigus (comparative analysis). Bulletin Dermatol Venereol. 2016;92(3):36–45. (In Russ). doi: 10.25208/0042-4609-2016-92-3-36-45

[76] Кубанов А.А., Абрамова Т.В. Применение клинико-диагностических индексов в оценке тяжести пузырчатки (сравнительный анализ) // Вестник дерматологии и венерологии. 2016. Т. 92, № 3. С. 36–45. doi: 10.25208/0042-4609-2016-92-3-36-45

[77] Sebaratnam D, Hanna AM, Chee SN, et al. Development of a quality-of-life instrument for autoimmune bullous disease: The autoimmune bullous disease quality of life questionnaire. JAMA Dermatol. 2013;149(10):1186–1191. doi: 10.1001/jamadermatol.2013.4972

[78] Sebaratnam D.F., Hanna A.M., Chee S.N., et al. Development of a quality-of-life instrument for autoimmune bullous disease: The autoimmune bullous disease quality of life questionnaire // JAMA Dermatol. 2013. Vol. 149, N 10. Р. 1186–1191. doi: 10.1001/jamadermatol.2013.4972

[79] Chen G, Yang B, Zhang Z, et al. Chinese version of the treatment of autoimmune bullous disease quality of life questionnaire: Reliability and validity. Indian J Dermatol Venereol Leprol. 2018;84(4):431–436. doi: 10.4103/ijdvl.IJDVL_538_16

[80] Chen G., Yang B., Zhang Z., et al. Chinese version of the treatment of autoimmune bullous disease quality of life questionnaire: Reliability and validity // Indian J Dermatol Venereol Leprol. 2018. Vol. 84, N 4. Р. 431–436. doi: 10.4103/ijdvl.IJDVL_538_16

[81] Behkar A, Garmaroudi G, Nasimi M, et al. Assessing quality of life in patients with autoimmune bullous diseases using the Persian version of treatment of autoimmune bullous disease quality of life questionnaire finds similar effects in women as men. Int J Women’s Dermatol. 2022;8(1):e004. doi: 10.1097/JW9.0000000000000004

[82] Behkar A., Garmaroud G., Nasimi M., et al. Assessing quality of life in patients with autoimmune bullous diseases using the Persian version of treatment of autoimmune bullous disease quality of life questionnaire finds similar effects in women as men // Int J Women’s Dermatol. 2022. Vol. 8, N 1. Р. e004. doi: 10.1097/JW9.0000000000000004

[83] Delavarian Z, Layegh P, Pakfetrat A, et al. Evaluation of desmoglein 1 and 3 autoantibodies in pemphigus vulgaris: Correlation with disease severity. J Clin Exp Dentistry. 2020;12(5):e440–e445. doi: 10.4317/jced.56289

[84] Delavarian Z., Layegh P., Pakfetrat A., et al. Evaluation of desmoglein 1 and 3 autoantibodies in pemphigus vulgaris: Correlation with disease severity // J Clin Exp Dentistry. 2020. Vol. 12, N 5. Р. e440–e445. doi: 10.4317/jced.56289

[85] Russo I, De Siena FP, Saponeri A, Alaibac M. Evaluation of anti-desmoglein-1 and anti-desmoglein-3 autoantibody titers in pemphigus patients at the time of the initial diagnosis and after clinical remission. Medicine. 2017;96(46):e8801. doi: 10.1097/MD.0000000000008801

[86] Russo I., De Siena F.P., Saponeri A., Alaibac M. Evaluation of anti-desmoglein-1 and anti-desmoglein-3 autoantibody titers in pemphigus patients at the time of the initial diagnosis and after clinical remission // Medicine. 2017. Vol. 96, N 46. Р. e8801. doi: 10.1097/MD.0000000000008801

[87] Singhvi G, Manchanda P, Rapalli V, et al. MicroRNAs as biological regulators in skin disorders. Biomed Pharmacother. 2018;(108):996–1004. doi: 10.1016/j.biopha.2018.09.090

[88] Singhvi G., Manchanda P., Krishna Rapalli V., et al. MicroRNAs as biological regulators in skin disorders // Biomed Pharmacother. 2018. N 108. Р. 996–1004. doi: 10.1016/j.biopha.2018.09.090

[89] Ruksha TG, Komina AV, Palkina NV. MicroRNA in skin diseases. Eur J Dermatol. 2017;27(4):343–352. doi: 10.1684/ejd.2017.3024

[90] Ruksha T.G., Komina A.V., Palkina N.V. MicroRNA in skin diseases // Eur J Dermatol. 2017. Vol. 27, N 4. Р. 343–352. doi: 10.1684/ejd.2017.3024

[91] Papara C, Zillikens D, Sadik CD, Baican A. MicroRNAs in pemphigus and pemphigoid diseases. Autoimmunity Rev. 2021;20(7):102852. doi: 10.1016/j.autrev.2021.102852

[92] Papara C., Zillikens D., Sadik C.D., Baican A. MicroRNAs in pemphigus and pemphigoid diseases // Autoimmunity Rev. 2021. Vol. 20, N 7. Р. 102852. doi: 10.1016/j.autrev.2021.102852

[93] Glavač D, Ravnik-Glavač M. Essential role of microRNA in skin physiology and disease. Adv Exp Med Biology. 2015;(888):307–330. doi: 10.1007/978-3-319-22671-2_16

[94] Glavač D., Ravnik-Glavač M. Essential role of microRNA in skin physiology and disease // Adv Exp Med Biol. 2015. N 888. Р. 307–330. doi: 10.1007/978-3-319-22671-2_16

[95] Baulina NM, Kulakova OG, Favorova OO. MicroRNA: A role in the development of autoimmune inflammation. Acta Naturae. 2016;8(1):23–36. (In Russ).

[96] Баулина Н.М., Кулакова О.Г., Фаворова О.О. МикроРНК: роль в развитии аутоиммунного воспаления // Acta Naturae (русскоязычная версия). 2016. Т. 8, № 1. C. 23–36.

[97] Lin N, Liu Q, Wang M, et al. Usefulness of miRNA-338-3p in the diagnosis of pemphigus and its correlation with disease severity. Peer J. 2018;(6):e5388. doi: 10.7717/peerj.5388

[98] Lin N., Li Q., Wang, M., et al. Usefulness of miRNA-338-3p in the diagnosis of pemphigus and its correlation with disease severity // Peer J. 2018. N 6. Р. e5388. doi: 10.7717/peerj.5388

[99] Xu M, Liu Q, Li S, et al. Increased expression of miR-338-3p impairs Treg-mediated immunosuppression in pemphigus vulgaris by targeting RUNX1. Exp Dermatol. 2020;29(7):623–629. doi: 10.1111/exd.14111

[100] Xu M., Liu Q., Li S., et al. Increased expression of miR-338-3p impairs Treg-mediated immunosuppression in pemphigus vulgaris by targeting RUNX1 // Exp Dermatol. 2020. Vol. 29, N 7. Р. 623–629. doi: 10.1111/exd.14111

[101] He W, Xing Y, Li C, et al. Identification of six microRNAs as potential biomarkers for pemphigus vulgaris: From diagnosis to pathogenesis. Diagnostics (Basel, Switzerland). 2022;12(12):3058. doi: 10.3390/diagnostics12123058

[102] He W., Xing Y., Li C., et al. Identification of six microRNAs as potential biomarkers for pemphigus vulgaris: From diagnosis to pathogenesis // Diagnostics (Basel, Switzerland). 2022. Vol. 12, N 12. Р. 3058. doi: 10.3390/diagnostics12123058

[103] Gareev IF, Beylerli OA. Circulating microRNAs as biomarkers: What are perspectives? Preventive Med. 2018;21(6):142–150. (In Russ).

[104] Гареев И.Ф., Бейлерли О.А. Циркулирующие микроРНК как биомаркеры: какие перспективы? // Профилактическая медицина. 2018. Т. 21, № 6. C. 142–150. doi: 10.17116/profmed201821061142

[105] Araviiskaia ER, Sokolovskiy EV. Microbiome: A new era in normal and pathological changes skin studies. Bulletin Dermatol Venereol. 2016;92(3):102–109. (In Russ). doi: 10.25208/0042-4609-2016-92-3-102-109

[106] Аравийская Е.Р., Соколовский Е.В. Микробиом: новая эра в изучении здоровой и патологически измененной кожи // Вестник дерматологии и венерологии. 2016. Т. 92, № 3. C. 102–109. doi: 10.25208/0042-4609-2016-92-3-102-109

[107] Boxberger M, Cenizo V, Cassir N, La Scola B. Challenges in exploring and manipulating the human skin microbiome. Microbiome. 2021;9(1):125. doi: 10.1186/s40168-021-01062-5

[108] Boxberger M., Cenizo V., Cassir N., La Scola B. Challenges in exploring and manipulating the human skin microbiome // Microbiome. 2021. Vol. 9, N 1. Р. 125. doi: 10.1186/s40168-021-01062-5

[109] Kong HH, Andersson B, Clavel T, et al. Performing skin microbiome research: A method to the madness. J Invest Dermatol. 2017;137(3):561–568. doi: 10.1016/j.jid.2016.10.033

[110] Kong H.H., Andersson B., Clavel T., et al. Performing skin microbiome research: A method to the madness // J Invest Dermatol. 2017. Vol. 137, N 3. Р. 561–568. doi: 10.1016/j.jid.2016.10.033

[111] Li BJ, He WX, Hua H, Pan W. Potential correlation of oral flora with pemphigus vulgaris: A case control study. J Dental Sci. 2023;18(4):1612-1620. doi: 10.1016/j.jds.2023.01.037

[112] Li B.J., He W.X., Hua H., Pan W. Potential correlation of oral flora with pemphigus vulgaris: A case control study // J Dental Sci. 2023. Vol. 18, N 4. P. 1612–1620. doi: 10.1016/j.jds.2023.01.037

[113] Künstner A, Sommer N, Künzel S, et al. Skin microbiota as potential trigger factors for pemphigus vulgaris. Exp Derm. 2018;27(3):e95. doi: 10.1111/exd.13486

[114] Künstner A., Sommer N., Künzel S., et al. Skin microbiota as potential trigger factors for pemphigus vulgaris // Experimental Derm. 2018. Vol. 27, N 3. P. e95. doi: 10.1111/exd.13486

[115] Scaglione G, Fania L, De Paolis E, et al. Evaluation of cutaneous, oral and intestinal microbiota in patients affected by pemphigus and bullous pemphigoid: A pilot study. Exp Mol Pathol. 2020;(112):104331. doi: 10.1016/j.yexmp.2019.104331

[116] Scaglione G.L., Fania L., De Paolis E., et al. Evaluation of cutaneous, oral and intestinal microbiota in patients affected by pemphigus and bullous pemphigoid: A pilot study // Exp Mol Pathol. 2020. N 112. Р. 104331. doi: 10.1016/j.yexmp.2019.104331

[117] Olisova OY, Teplyuk NP. An illustrated guide to dermatology. For preparing practitioners for accreditation. Moscow: GEOTAR-Media; 2023. 376 р. (In Russ).

[118] Олисова О.Ю., Теплюк Н.П. Иллюстрированное руководство по дерматологии для подготовки врачей к аккредитации. Москва: ГЭОТАР-Медиа, 2023. 376 с.

Funding

НИЦ «Курчатовский институт»NRC “Kurchatov Institute”

RIGHTS & PERMISSIONS

Eco-Vector